Evidence map›Paper›PMID 36195833›Full record

ArticleBMC cancer2022

Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer.

Erbao Chen, Jing Yi, Jing Jiang, Zhilin Zou, Yuqian Mo, Qingqi Ren, Zewei Lin, Yi Lu, Jian Zhang, Jikui Liu

Abstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Clinical Significance ofDiseases (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Erbao Chen *School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
Jing Yi *Hepato-Pancreato-Biliary Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.
Jing Jiang *Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.
Zhilin ZouDepartment of Ophthalmology, Affiliated Eye Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China.
Yuqian MoSchool of Public Health, Guangdong Medical University, Zhanjiang, 524023, Guangdong, China.
Qingqi RenHepato-Pancreato-Biliary Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.
Zewei LinHepato-Pancreato-Biliary Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.
Yi LuSchool of Medicine, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
Jian ZhangSchool of Medicine, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China. zhangjian@sustech.edu.cn.
Jikui LiuHepato-Pancreato-Biliary Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China. liu8929@126.com.

Funding

China Postdoctoral Science Foundation 2020M682779National Natural Science Foundation of China 81972420National Natural Science Foundation of China 81972766Science and Technology Planning Project of Shenzhen Municipality JCYJ20170412154619484Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20190809095801653Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20190809100217290Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20190809161811237Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ2021032410424040
6 · The paper itself

Abstract

backgroundFatty acid (FA) metabolism is considered the emerging cause of tumor development and metastasis, driving poor prognosis. Long non-coding RNAs (lncRNAs) are closely related to cancer progression and play important roles in FA metabolism. Thus, the discovery of FA metabolism-related lncRNA signatures to predict outcome and immunotherapy response is critical in improving the survival of patients with hepatocellular carcinoma (HCC).

methodsFA metabolism scores and a FA metabolism-related lncRNA signature were constructed using a single-sample gene set enrichment analysis based on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. "ConsensusClusterPlus" was used to screen molecular subtypes. Chi-squared test and Fisher's exact test were applied to explore the relationship between clinical, genomic mutation characteristics and subtypes. Transcription factor (TF) activity scores, cellular distributions, immune cell infiltration, and immunotherapy response were employed to investigate the functions of FA metabolism-related lncRNA signatures. FA metabolism microarray and western blot were performed to detect the biological function of candidate lncRNAs.

resultsA total of 70 lncRNAs that highly correlated with FA metabolism scores in two cohorts were used to construct two distinct clusters. Patients in cluster 2 had lower FA metabolism scores and worse survival than those in cluster 1. Patients in cluster 2 exhibited a high frequency of DNA damage, gene mutations, oncogenic signaling such as epithelial-to-mesenchymal transition, and a high degree of immune cell infiltration. Moreover, the lncRNA signature could predict the effects of immunotherapy in patients with HCC. Furthermore, three lncRNAs (SNHG1, LINC00261, and SNHG7) were identified that were highly correlated with FA metabolism. Additionally, SNHG1 and SNHG7 were found to regulate various FA metabolism-related genes and ferroptosis-related genes in vitro experiments. GSEA analysis revealed that SNHG1 and SNHG7 promote fatty acid beta-oxidation. SNHG1 and SNHG7 silencing dramatically reduced lipid droplets in HCC cells. Many immune-infiltration genes and TFs were overexpressed in HCC tissues with SNHG1 and SNHG7 high expression.

conclusionsA novel molecular model of FA metabolism-related lncRNAs was developed, which has significantly prognostic potential in HCC diagnosis and aids in clinical decision making.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsRNA, Long NoncodingFatty AcidsGene Expression Regulation, NeoplasticHumansImmunotherapyPrognosisTranscription FactorsFatty AcidsRNA, Long NoncodingTranscription FactorsFatty acid metabolismFerroptosisHepatocellular carcinomaImmune infiltrationsLncRNA

Identifiers

PMID36195833
PMCPMC9531484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.